Literature DB >> 12667639

Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells.

Masayoshi Shichiri1, Nozomi Fukai, Naoko Ozawa, Hiroaki Iwasaki, Yukio Hirata.   

Abstract

Adrenomedullin is a potent vasodilator peptide secreted by vascular endothelial and smooth muscle cells. Adrenomedullin stimulates the proliferation of quiescent rat vascular smooth muscle cells (VSMCs) via p42/p44 ERK/MAP kinase activation. Recently, receptor-activity-modifying proteins (RAMPs) have been shown to transport calcitonin-receptor-like-receptor (CRLR) to the cell surface to present either as CGRP receptor or adrenomedullin receptor. We investigated whether adrenomedullin acts as an autocrine/paracrine growth factor for cultured rat VSMCs and whether coexpressions of RAMP isoform and CRLR may mediate p42/p44 ERK/MAP kinase activation by adrenomedullin. Adrenomedullin dose-dependently stimulated the proliferation of quiescent rat VSMCs, and this effect was inhibited by an adrenomedullin receptor antagonist, a MAP kinase kinase inhibitor and phosphatidylinositol 3-kinase inhibitors. Addition of either CGRP(8-37) or anti-adrenomedullin antibody to exponentially growing rat VSMCs inhibited the serum-induced cell proliferation, suggesting its role as an autocrine/paracrine growth factor. Cotransfection of RAMP2 or RAMP3 with CRLR into rat VSMCs potentiated activation of cAMP activity, but not of p42/p44 ERK/MAP kinase activity in response to adrenomedullin. Our results suggest that adrenomedullin is an autocrine/paracrine growth factor for rat VSMCs via p42/p44 ERK/MAP kinase and phosphatidylinositol 3-kinase pathways and that it is not mediated by human RAMP-CRLR receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667639     DOI: 10.1016/s0167-0115(03)00036-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization.

Authors:  Christopher F MacManus; Eric L Campbell; Simon Keely; Adrianne Burgess; Douglas J Kominsky; Sean P Colgan
Journal:  FASEB J       Date:  2011-02-24       Impact factor: 5.191

2.  SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.

Authors:  Changge Fang; Ingalill Avis; Caterina Bianco; Natalie Held; Jennifer Morris; Kris Ylaya; Stephen M Hewitt; Alfred C Aplin; Roberto F Nicosia; Laura A Fung; John D Lewis; William G Stetler-Stevenson; David S Salomon; Frank Cuttitta
Journal:  Open J Clin Diagn       Date:  2013-06

3.  A role for the sensory neuropeptide calcitonin gene-related peptide in endothelial cell proliferation in vivo.

Authors:  Paul I Mapp; Daniel F McWilliams; Matthew J Turley; Edward Hargin; David A Walsh
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene.

Authors:  Ryan T Dackor; Kimberly Fritz-Six; William P Dunworth; Carrie L Gibbons; Oliver Smithies; Kathleen M Caron
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma.

Authors:  Xing Dai; Wei Ma; Xijing J He; Rajiv Kumar Jha
Journal:  Med Oncol       Date:  2012-12-27       Impact factor: 3.064

6.  Equine Chorionic Gonadotropin Modulates the Expression of Genes Related to the Structure and Function of the Bovine Corpus Luteum.

Authors:  Liza Margareth Medeiros de Carvalho Sousa; Gabriela Pacheco Mendes; Danila Barreiro Campos; Pietro Sampaio Baruselli; Paula de Carvalho Papa
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 7.  Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Authors:  Nikolas Rapp; Pieter Evenepoel; Peter Stenvinkel; Leon Schurgers
Journal:  Toxins (Basel)       Date:  2020-09-29       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.